Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Am J Ophthalmol. 2019 Mar 6;203:78–88. doi: 10.1016/j.ajo.2019.02.029

Table 4.

Effect of IOP on 3 Year Graft Success

N 3-yr Graft Success (99% CI) Hazard Ratio (99% CI) P value

History of glaucoma/ Postoperative Abnormal IOP at least 1 month following DSAEK N=1277 0.28

 No/No 927 97.9% (96.1%, 98.9%) 1.00
 Yes/No 55 98.1% (78.2%, 99.9%) 0.77 (0.05, 11.66)
 No/Yes 239 95.8% (90.2%, 98.2%) 1.81 (0.60, 5.47)
 Yes/Yes 56 91.8% (73.3%, 97.7%) 2.59 (0.50, 13.41)

Early Acute IOP Event N=1330 0.008

 No 1306 94.1% (92.1%, 95.6%) 1.00
 Yes 24 75.0% (43.8%, 90.5%) 3.42 (1.01, 11.53)

IOP = intraocular pressure; DSAEK = Descemet stripping automated endothelial keratoplasty

a.

Base model adjusted for PT, recipient diagnosis, donor history of diabetes, operative complications, and surgeon effects

b.

History of glaucoma defined as had glaucoma surgery, and/or on glaucoma medications

c.

Postoperative abnormal IOP defined as had new glaucoma surgery, or put on new glaucoma meds without new glaucoma surgery, or had IOP > 25 m Hg without any new glaucoma surgery or medications. (Eyes failed or censored within 1 month following DSAEK were eliminated). New glaucoma surgery performed included: tube shunt only (5 eyes), trabeculectomy only (2 eyes), laser trabeculoplasty only (3 eyes), and all 3 procedures (1 eye) in 11 participants.

d.

Early acute IOP defined as any occurrence of IOP>40 or paracentesis for pupillary block or angle closure in the first week post-operatively